Moors & Cabot’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.36M | Sell |
88,308
-11,495
| -12% | -$584K | 0.17% | 118 |
|
|
2026
Q1 | $5.32M | Sell |
99,803
-1,204
| -1% | -$70.7K | 0.23% | 93 |
|
|
2025
Q4 | $6.28M | Buy |
101,007
+1,505
| +2% | +$92.9K | 0.27% | 75 |
|
|
2025
Q3 | $5.98M | Sell |
99,502
-556
| -0.6% | -$34K | 0.26% | 75 |
|
|
2025
Q2 | $6.27M | Buy |
100,058
+920
| +0.9% | +$55.3K | 0.29% | 71 |
|
|
2025
Q1 | $5.97M | Buy |
99,138
+663
| +0.7% | +$41.2K | 0.3% | 67 |
|
|
2024
Q4 | $5.75M | Sell |
98,475
-158
| -0.2% | -$9.39K | 0.27% | 74 |
|
|
2024
Q3 | $5.84M | Sell |
98,633
-1,668
| -2% | -$95.3K | 0.29% | 74 |
|
|
2024
Q2 | $5.62M | Sell |
100,301
-1,492
| -1% | -$83.5K | 0.3% | 70 |
|
|
2024
Q1 | $5.96M | Buy |
101,793
+1,713
| +2% | +$96.7K | 0.32% | 65 |
|
|
2023
Q4 | $5.4M | Buy |
100,080
+324
| +0.3% | +$15.8K | 0.34% | 66 |
|
|
2023
Q3 | $4.84M | Sell |
99,756
-4,834
| -5% | -$257K | 0.33% | 70 |
|
|
2023
Q2 | $5.91M | Sell |
104,590
-4
| -0% | -$220 | 0.39% | 53 |
|
|
2023
Q1 | $5.65M | Sell |
104,594
-313
| -0.3% | -$16.7K | 0.39% | 53 |
|
|
2022
Q4 | $5.51M | Buy |
104,907
+899
| +0.9% | +$45.6K | 0.38% | 56 |
|
|
2022
Q3 | $4.91M | Sell |
104,008
-479
| -0.5% | -$24.9K | 0.37% | 57 |
|
|
2022
Q2 | $5.27M | Buy |
104,487
+791
| +0.8% | +$43.1K | 0.38% | 58 |
|
|
2022
Q1 | $6.32M | Buy |
103,696
+2,815
| +3% | +$168K | 0.39% | 57 |
|
|
2021
Q4 | $6.64M | Buy |
100,881
+1,250
| +1% | +$80K | 0.41% | 53 |
|
|
2021
Q3 | $6.26M | Buy |
99,631
+3,547
| +4% | +$226K | 0.39% | 53 |
|
|
2021
Q2 | $5.78M | Buy |
96,084
+2,790
| +3% | +$161K | 0.41% | 57 |
|
|
2021
Q1 | $5.14M | Buy |
93,294
+8,418
| +10% | +$467K | 0.39% | 61 |
|
|
2020
Q4 | $4.63M | Buy |
84,876
+252
| +0.3% | +$13.2K | 0.39% | 61 |
|
|
2020
Q3 | $4.23M | Buy |
84,624
+23,856
| +39% | +$1.16M | 0.4% | 60 |
|
|
2020
Q2 | $2.68M | Buy |
60,768
+27,834
| +85% | +$1.19M | 0.29% | 85 |
|
|
2020
Q1 | $1.24M | Buy |
32,934
+21,648
| +192% | +$912K | 0.18% | 119 |
|
|
2019
Q4 | $497K | Sell |
11,286
-594
| -5% | -$25K | 0.05% | 344 |
|
|
2019
Q3 | $489K | Buy |
11,880
+2,028
| +21% | +$83K | 0.05% | 338 |
|
|
2019
Q2 | $394K | Buy |
9,852
+600
| +6% | +$22.7K | 0.05% | 351 |
|
|
2019
Q1 | $356K | Buy |
9,252
+150
| +2% | +$5.45K | 0.05% | 350 |
|
|
2018
Q4 | $303K | Buy |
9,102
+504
| +6% | +$17.5K | 0.05% | 363 |
|
|
2018
Q3 | $325K | Buy |
8,598
+2,592
| +43% | +$92.1K | 0.04% | 409 |
|
|
2018
Q2 | $200K | Sell |
6,006
-600
| -9% | -$19.5K | 0.03% | 515 |
|
|
2018
Q1 | $204K | Buy |
+6,606
| New | +$203K | 0.03% | 532 |
|
Other funds holding IHI
AAS
Moors & Cabot's IHI Position: Q2 2026 in Review
Moors & Cabot reduced its iShares US Medical Devices ETF (IHI) stake by 12% in Q2 2026, selling an estimated $584K and leaving 88,308 shares worth $4.36M. The position accounts for 0.17% of the portfolio, ranked #118.
Moors & Cabot first reported a position in IHI in Q1 2018 and has held it in 34 quarters since. The position peaked at $6.64M in Q4 2021. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Moors & Cabot held 88,308 shares of iShares US Medical Devices ETF worth $4.36M as of Q2 2026.
- Moors & Cabot sold 11,495 iShares US Medical Devices ETF shares in Q2 2026, an estimated $584K.
- iShares US Medical Devices ETF made up 0.17% of Moors & Cabot's portfolio in Q2 2026, its #118 holding.
- Moors & Cabot first reported a position in iShares US Medical Devices ETF in Q1 2018 and has held it in 34 quarters since.
- Moors & Cabot's iShares US Medical Devices ETF position peaked at $6.64M in Q4 2021.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.